IP Library Granted Patent US 10,034,740
Granted Patent B2
US 10,034,740 · App. 13/169,715 · Granted Jul 31, 2018

Covered stent

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,034,740
App. No.
13/169,715
Granted
Jul 31, 2018
Kind
B2
Abstract

A covered stent having a selected arrangement of uncovered cells is provided. The uncovered cells are configured to provide a desired flexibility profile to the stent structure. In one preferred embodiment, the stent contains one or more circumferential rows of uncovered cells located between two or more circumferential rows of covered cells. In some embodiments, the stent may have a central body portion and one or more flanges where the circumferential rows of uncovered cells may be located within the flange(s).

Claims (8)

1. A self-expanding braided stent, comprising:

a central body portion disposed between a pair of flanges, the pair of flanges each having an expanded diameter greater than an expanded diameter of the central body portion;

a plurality of fully membrane covered circumferential rows of cells, wherein the membrane comprises a flexible non-biodegradable material biased in an expanded cell configuration and configured to permit both full radial expansion of the stent and contact against a vessel wall of a bodily lumen upon initial deployment thereof within the bodily lumen; and

a plurality of fully uncovered circumferential rows of cells, wherein the fully uncovered circumferential rows of cells are located between at least two circumferential rows of fully membrane covered cells, and wherein at least one of the fully uncovered circumferential rows of cells completely circumscribes each of the flanges of the stent.

2. The stent of claim 1 , wherein the fully membrane covered circumferential row of cells does not prevent expansion of the stent.

3. The stent of claim 1 , wherein, upon initial deployment, the membrane is configured to permit radial expansion of the stent into contact against the vessel wall of the bodily lumen.

4. The stent of claim 1 , wherein the plurality of fully uncovered circumferential rows of cells comprises at least two adjacent fully uncovered circumferential rows of cells completely circumscribing the stent.

5. The stent of claim 4 , wherein the at least two fully uncovered circumferential rows of cells completely circumscribing the stent are bordered on each side by a circumferential row of membrane covered cells.

Assignments (3)
SECURITY INTEREST Recorded Feb 28, 2024
From: COOK MEDICAL TECHNOLOGIES LLC
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 066700/0277 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2011
From: RYAN, MICHAEL
To: COOK IRELAND LIMITED
Reel/Frame 026523/0187 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2011
From: COOK IRELAND LIMITED
To: COOK MEDICAL TECHNOLOGIES LLC
Reel/Frame 026523/0216 →
Cited By (1)
US 12,521,225